Zegalogue is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Zealand Pharma A/s. The primary component is Dasiglucagon.
| Product ID | 80644-0012_befd6f41-152c-ca68-e053-2995a90acbc0 |
| NDC | 80644-0012 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Zegalogue |
| Generic Name | Dasiglucagon |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2021-04-05 |
| Marketing Category | NDA / |
| Application Number | NDA214231 |
| Labeler Name | Zealand Pharma A/S |
| Substance Name | DASIGLUCAGON |
| Active Ingredient Strength | 1 mg/.6mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-04-05 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 80644-0012 | Zegalogue | dasiglucagon |
| 80644-0013 | Zegalogue | dasiglucagon |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ZEGALOGUE 79256691 5905935 Live/Registered |
ZEALAND PHARMA A/S 2019-01-14 |